AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
RANIBIZUMAB
14 registrations across 11 African markets— 13 active
Markets with RANIBIZUMAB
🇲🇦Morocco
2 registrations
2 active
🇺🇬Uganda
2 registrations
2 active
🇬🇭Ghana
2 registrations
2 active
🇸🇳Senegal
1 registration
1 active
🇹🇳Tunisia
1 registration
0 active
🇹🇿Tanzania
1 registration
1 active
🇿🇦South Africa
1 registration
1 active
🇿🇲Zambia
1 registration
1 active
🇿🇼Zimbabwe
1 registration
1 active
🇰🇪Kenya
1 registration
1 active
🇷🇼Rwanda
1 registration
1 active
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| BioUcenta Solution for Injection | 🇷🇼Rwanda | Polpharma Biologics S.A | active | Oct 2030 |
| Lucentis Injection Solution For Injection | 🇰🇪Kenya | Novartis | active | Sept 2030 |
| Patizra Solution for Injection Solution for Injection | 🇿🇲Zambia | Novartis Pharma Services | active | Dec 2029 |
| PATIZRA SOLUTION; INJECTION | 🇿🇼Zimbabwe | NOVARTIS PHARMA SERVICES AG | active | Dec 2027 |
| BIOUCENTA (RANIBIZUMAB) 10MG/ML SOLUTION FOR INJECTION | 🇬🇭Ghana | — | active | Dec 2026 |
| BIOUCENTA (RANIBIZUMAB) 10MG/ML SOLUTION FOR INJECTION | 🇬🇭Ghana | — | active | Dec 2026 |
| LUCENTIS Solution injectable / 10mg/ml | 🇹🇳Tunisia | NOVARTIS PHARMA SCHWEIZ AG | expired | Oct 2013 |
| LUCENTIS | 🇿🇦South Africa | Novartis South Africa (Pty) Ltd | active | Jan 1900 |
| Patizra Solution for injection | 🇹🇿Tanzania | NVS Kenya Limited | active | — |
| LUCENTIS solution injectable / 10mg / ml | 🇸🇳Senegal | NOVARTIS PHARMA | active | — |
| LUCENTIS 10MG/ML SOLUTION INJECTABLE | 🇲🇦Morocco | — | active | — |
| LUCENTIS 10MG/ML SOLUTION INJECTABLE | 🇲🇦Morocco | — | active | — |
| RANIBIZUMAB PARENTERAL
ORDINARY VIALS | 🇺🇬Uganda | NVS KENYA LTD | active | — |
| RANIBIZUMAB PARENTERAL
ORDINARY VIALS | 🇺🇬Uganda | NVS KENYA LTD | active | — |
RANIBIZUMAB in Africa — Regulatory Overview
RANIBIZUMAB is registered across 11 African markets with 14 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Morocco, Uganda, Ghana, Senegal and 7 more. AfricaRegulatory refreshes this data daily from official government sources.
Of the 14 registrations, 13 (93%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.